Gossamer Bio is a clinical-stage biopharmaceutical company dedicated to developing and commercializing seralutinib for treating pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company focuses on enhancing the lives of people living with rare diseases, offering a distinctive approach in its industry by targeting these specific conditions with precision.
The Assoc. Director / Dir of Regional Medical Affairs (RMAs) will lead the medical affairs team focusing on Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension–Interstitial Lung Disease (PH-ILD), serving as a key partner with clinical and other teams to ensure cohesive strategies and execution. This role involves strategic planning, team leadership, and collaboration with cross-functional teams to drive impactful outcomes and align with company goals.
Gossamer Bio is a clinical-stage biopharmaceutical company dedicated to developing and commercializing seralutinib for treating pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company focuses on enhancing the lives of people living with rare diseases, offering a distinctive approach in its industry by targeting these specific conditions with precision.
Arcellx